ADAM17 and gastric cancer: P65, an anti-apoptosis regulator, one of the molecules downstream TNFα, was reduced once ADAM17 downregulated, suggesting that ADAM17 promoted the development of gastric cancer through the regulation of TNFα signaling pathway [58].